TheraRadar

Pharma Intelligence, Simplified

← Back
Data updated: Mar 10, 2026

CSPC OUYI

GastroenterologyInfectious DiseaseOncology
Generics

CSPC OUYI is a generic drug manufacturer focused on Gastroenterology, Infectious Disease, Oncology. Key products include ESOMEPRAZOLE MAGNESIUM.

2005
Since
13
Drugs
-
Trials
332
Approved (2yr)

Key Drugs

No active drugs

Recent Activity

GABAPENTIN 2026-02-24
Labeling
GABAPENTIN 2026-02-18
Labeling
GABAPENTIN 2026-02-17
Labeling
GABAPENTIN 2026-02-17
Labeling
TRAMADOL HYDROCHLORIDE 2026-02-13
Labeling
TRAMADOL HYDROCHLORIDE 2026-02-13
Labeling
CELECOXIB 2026-02-12
Labeling
GABAPENTIN 2026-02-12
Labeling
TRAMADOL HYDROCHLORIDE 2026-02-12
Manufacturing (CMC)
GABAPENTIN 2026-01-29
Labeling
SEC Filings Pro
Loading...

Therapeutic Focus

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Gastroenterology 25%
2 drugs Phase 2: 1
Infectious Disease 22%
2 drugs
Oncology 20%
0 drugs Phase 3: 1 Phase 2: 3 Phase 1: 1
Neurology 18%
1 drugs Phase 3: 1
Dermatology 15%
1 drugs Phase 2: 1

Pipeline Strength Pro

Loading...

Competitors Pro

Pfizer big-pharma
Oncology, Infectious Disease, Dermatology, Gastroenterology
Bristol-Myers Squibb big-pharma
Oncology, Gastroenterology, Infectious Disease, Neurology
Baxter specialty
Infectious Disease, Oncology, Dermatology
AbbVie big-pharma
Oncology, Neurology, Infectious Disease
GSK big-pharma
Infectious Disease, Oncology, Neurology